bluuebunny/crossref_metadata_2025_split huggingface dataset:
P02-342 - Lifetrack Therapy Overcomes Depression Through Bringing the Patient Far Closer to his/her Partner than Ever Before
Authors: Ishizuka Y. 
Published: June 2010

Objective of this presentation is to demonstrate that depression is a part of natural responses by one's personality when its past experience and current capability to cope is exceeded by life challenges. Accordingly, Lifetrack therapy attempts to modify patient's personality in such ways that thresohold of tolerance can be signficantly raised, eliminating depression by making it unnecessary.Working with the patient and his/her partner, Lifetrack thereapist focuses almost exclusively on bringing the couple closer than ever before, guided by their own daily self-rating on 41 parameters that allows accurate graphic tracking of dynamic mental status and subtle daily changes in their personalities via Internet. A series of 26 revealing graphs are examined during each session.As the case example of Mike (35 year old executive who became severely depressed and was hospitalized after attempting suicide in career crisis) illustrates, his closeness with his wife advanced far beyond previous maximum level through Lifetrack therapy, provoking and overcoming waves of defense (symptom spikes including depression) until symptoms became weakened by exhaustion and disappeared in 1.5 month. In 2.5 months, he returned to the same difficult job directly from hospital and thrived on it.Of the 1,200 cases manifesting various degrees of depressive symptoms, 61.4% of patients treated with partner (871) exceeded their previous maximum level of adjustment according to their own daily selfrating. When couples persisted beyond the first month of therapy, 77.3% exceeded their previous maximum level. 86.6% did so when they persisted beyond three months in thereapy.
P02-343 - The psychoanalytic Treatment of a Seven Year-Old boy, Victim of Sexual Abuse
Authors: Jacintho A.C.d.Á. , Pereira M.E.C. 
Published: June 2010

ObjectiveTo report and discuss the use of psychoanalytic treatment for children victims of sexual abuse.MethodWe report the psychoanalytic therapy of a seven year-old boy, sexually abused, discussing the “play technique” developed by Melanie Klein.ResultsThe boy does not speak to the analyst about the abuse. He has serious changes in his behavior and attempted suicide after that. In the first session with play materials, he draws a heart and partially paints it black, writing his name in it. He is very uncomfortable with the stains caused by black pencil on the white paper sheet. With scissors he cuts the heart and places it on the stretcher. He throws away the stained paper in the waste paper basket. Then he plays the game of catch-rods. At the end of the session, he puts all the toys in the box, and gives to the analyst the “cut up heart” that was on the stretcher, saying that it should be kept under the analyst's care.ConclusionWith the use of the toy, Klein was able to extend the psychoanalytic concepts proposed by Freud from the analysis of adults, allowing children to be analyzed. By playing, children symbolically represent their fantasies, anxieties and defenses, expressing their models of relationship with the world. In the session of “play therapy”, children can communicate their anxieties and also find resources for the overcoming of their traumas. With his “cut up heart”, the child communicates his suffering, requiring care from the analyst.
P02-348 - Cognitive Behavioral Wisdom Psychotherapy in the Treatment of Posttraumatic Embitterment Disorders
Authors: Linden M. , Baumann K. , Lieberei B. 
Published: June 2010

BackgroundNegative life events can result in adjustment disorders. If there are feelings of having been treated unfair, been let down or been humiliated one type of reaction are prolonged states of embitterment, which has been described as Posttraumatic Embitterment Disorder, PTED. A new approach in the treatment of PTED is cognitive behavioral psychotherapy which uses special strategies based on wisdom psychology. Wisdom has been defined as the capacity to cope with unsolvable and serious problems and questions in life.MethodIn a controlled clinical trial psychosomatic inpatients which suffered from PTED, were randomly assigned to “wisdom therapy” (N=28), which focusses on the reframing of the traumatic event and to “wisdom and headonia therapy” (N=29), which additionally encourages patients to focus on positive aspects in life. Another group of PTED patients (N=50) and patients with other mental disorders (N=50) received treatment as usual.ResultsPTED patients who were treated with wisdom psychotherapy showed a reduction in the SCL-90-PST score of initially 55,7 and at the end of 40,1 and those treated with hedonia therapy of initially 58,7 and at the end of 41,3. Measures of therapist adherence showed that therapists in both groups used wisdom strategies. PTED controls started initially with a SCL-90-PST score of 52,2 and ended with 50,2. Other patients started treatment with 39,3 and finished with 25,9.DiscussionThis first treatment study on cognitive wisdom therapy suggests that wisdom can be helpful in the treatment of adjustment and embitterment disorders.
P02-355 - 10 Years Re-Evaluation of Number of Psychiatric Residents Involved in Training in Psychotherapy in Romania
Authors: Buftea L. , Cretu C. , Mihai A. 
Published: June 2010

PurposeAs this is a time of great change in Romanian psychiatry we considered it was useful to analyze the availability of various types of psychotherapy and the commitment of psychiatry residents to psychotherapy training, comparing with data from 1998.MethodSame protocol study like in 1998 was used. The data from National Centre for Medical Training were analyzed. We examined the total number of residents undergoing psychotherapy training, year of residency and the type of psychotherapy they chose.ResultsIn 2009, there are 726 psychiatry residents in Romania (180 in 1998) distributed in 11 (6 in 1998) university training centres. We registered a response rate of 81.8% (77.7% in 1998), and only 30.13% residents are involved/ in a specific psychotherapy training comparing with 48.5% in 1998. The types of psychotherapy were: cognitive behavioural therapy, positive psychotherapy, transactional analysis, psychoanalysis, psychodrama, hypnosis, existential psychotherapy.ConclusionEven though training in psychotherapy is included in curricula like compulsory topic since 2007, the availability of psychotherapeutic training for residents is still restricted, due to high costs, the need to self-finance the training, organizational difficulties and low number of training centres and trainers.
P02-360 - Effect of CBT-Based Sex Offenders Therapy on Cognitive Distortions of Learning Disabled Male Sex-Offencers in a Forensic Unit
Authors: Kundi P.S. , Sharma D. , Magombedze R. 
Published: June 2010

ObjectivesThe aim of our study was to compare the cognitive distortions in learning-disabled male sex-offenders before and after the administration of full 52-weeks Sex-Offenders Treatment Programme(SOTP).MethodsAs a part of the CBT-based Sex-Offenders Treatment Programme, 17 male adults were referred for therapy(over a period of 2 years) out of which 12 were accepted for SOTP. Mean age of the subjects was 32.5 years(Range: 22-50 years) and mean IQ was 65.16(Range: 53-75).SOSAS(Sexual-Offenders Self-Appraisal Scale) was administered both pre and post treatment. This instrument consists of 20 statements from four sub-scales: Denial, Victim Blaming, Minimization and Realism to which each respondent was asked to indicate his degree of agreement or disagreement.ResultsWe noticed an improvement in Denial and Minimization scores in 58% of cases, Victim Blame scores in 25% of cases and Realism scores in 67% of cases.There was a little (< 5%) or no change in 25% of Denial scores, 17% of Victim Blame scores and 9% of Minimization and Realism scores.A deterioration in 17% of Denial scores, 58% of Victim Blame scores, 33% of Minimization scores and 24% of Realism scores.ConclusionsOur results reveal beneficial effect of SOTP on the cognitive distortions of Denial, Minimization and Realism in more than half of the patients but deterioration in the cognitive distortion of Blame.While the results suggest CBT-based Sex Offenders Treatments are beneficial in modifying cognitive distortions, further research is needed to validate the effectiveness of this approach, especially in long-term follow up studies.
P03-103 - Importance of the Long-Acting Inyectable Neuroleptics in the Evolutive Course of Schizophrenia: Clinical and Neurocognitive Assessment
Authors: Pérez-García M. , Páramo-Fernandez M. , Mozos-Ansorena A. , Brenlla-Gonzalez J. , Portela-Traba B. 
Published: June 2010

IntroductionIn spite that the patients with long-acting neuropletics(LAN)can drop out and have relapses,its use allows a more long-lasting time and more stable plasmatic concentrations that supply clinical and neurocognitive advantages.ObjectiveTo analyze the symptomatology and neurocognitive differences(P300)among the patients that relapse after withdrawing from the previous treatment with oral antipsychotic as regards those treated with LAN.Material and methods34 schizophrenic patients with a history of at least one admission in a acute adult psychiatric ward.All the patients have been assessed with the Positive and Negative Syndrome Scale (PANSS) and with potential auditory evocations(wave P300).ResultsClinical profile: 73.5% suffers from paranoid schizophrenia.Only 32.4% shows antipsychotic monotherapy;the 61.8% have been prescribed with long-acting Risperidone.PANSS: The patients who had at least two admissions and who in the previous admission received long-acting Risperidone,showed a PANSS-N punctuation lower than the rest of the patients(21.64±4.6 vs. 25.4±3.2)at the end of the last admission(p=0.037).The same takes place with PANSS-PG at the end of the last admission(30.71 ± 3.8 vs. 3.61 ± 5.89(p=0.012).P300: The latency measures of P300 are lower in those patients who in the previous admission received a long-acting Risperidone treatment(average of 314±34.65msec vs. 344.67±24.67msec),being the differences statistically relevant(p=0.012).The ranges are higher in the patients treated with long-acting Risperidone in the previous admission(average 5.3 ± 2.44vs.5±2.64 μV),though the differences are not statistically relevant.ConclusionsAt the end of the last admission,the patients who in the previous admission received long-acting Risperidone,showed a PANSS-N,a PANSS-PG and a latency of P300 lower than the rest of the patients but the range of P300 was higher.
P03-104 - Linguistic Production and Comprehension Deficits in Schizophrenia and Bipolar Disorder
Authors: Perlini C. , Marini A. , Fabbro F. , Garzitto M. , Cerruti S. , Marinelli V. , Rambaldelli G. , Ferro A. , Tomelleri L. , Bellani M. , Tansella M. , Brambilla P. 
Published: June 2010

IntroductionAlthough language deficits have often been reported in schizophrenia, the specific relevance of single linguistic levels of processing is still under debate. Moreover, little is known about language disturbances in bipolar disorder.ObjectivesThe aims of this study were to:1)investigate micro-linguistic (lexicon, morphology, syntax) and macro-linguistic (discourse coherence, pragmatics) dimensions of speech production and2)evaluate syntactic comprehension skills in both schizophrenia and, for the first time, bipolar disorder.MethodsA story telling task and a computer-based test of syntactic comprehension were administered to 30 Italian speaking DSM-IV patients suffering from schizophrenia, 30 participants with bipolar disorder and 30 healthy controls, comparable for age and educational level (p>0.05). Analysis of variance with post-hoc correction was performed to compare linguistic performance between groups.ResultsIn comparison to healthy participants, patients with schizophrenia had significantly impaired productivity, syntactic complexity and local/global discourse coherence and bipolar disorder subjects showed deficits in mean length of utterance (p< 0.05). Also, both groups of patients collected more grammatical errors than controls (p< 0.05), but they differed in regard to the grammatical type of construction they missed (passive-affirmative and active-negative, respectively).ConclusionsOur results showed the presence of both micro and macro-linguistic deficits in linguistic production in schizophrenia, but not in bipolar disorder, suggesting that these abnormalities are specific for schizophrenia. On the contrary, syntactic construction comprehension was altered in both schizophrenia and bipolar disorder, potentially representing the target of innovative rehabilitation strategies.
P03-107 - Clinical Remission, Cognitive Functions and Functional Outcome in Schizophrenia
Authors: Piegari G. , Bucci P. , Ardizio E. , De Simone S. , De Riso F. , Mucci A. , Galderisi S. 
Published: June 2010

ObjectivesAn impairment of several cognitive domains has been largely documented in patients with schizophrenia. The present study aimed to investigate the relationships between cognitive functioning, symptomatic remission and functional outcome in schizophrenia.MethodsThe performance on the neuropsychological battery “Brief Assessment of Cognition in Schizophrenia (BACS)” has been investigated in clinically remitted (R) and non-remitted (NR) schizophrenic patients. The associations of neuropsychological performance with psychopathological dimensions derived from PANSS and indices of social functioning (as assessed by the Global Assessment of Functioning scale, the Personal and Social Performance scale, the Quality of Life Scale, the UCSD Performance-Based Skills Assessment-Brief Version and the Psychosocial Remission in Schizophrenia scale) were also explored by means of multiple regression (MR) analyses.ResultsCompared with NR, R patients showed a better performance on tests exploring executive functions, processing speed and verbal fluency. Residual negative symptoms and processing speed were independent predictors of functional outcome, while remission status did not enter the MR function.ConclusionsOur findings suggest that cognitive abilities, in particular processing speed and executive functions, are preserved in patients who are able to reach clinical remission. Independently from the remission state or residual negative symptomatology, processing speed also predicts functional outcome in schizophrenia. Our findings support the view that cognitive dysfunctions in schizophrenia should be targeted by specific treatment intervention, such as neurocognitive rehabilitation.
P03-120 - Assessment of a New Memory Training Instrument for Patients with Schizophrenia
Authors: Ojeda N. , Peña J. , Bengoetxea E. , Sánchez P.M. , Elizagárate E. , Segarra R. , Ezcurra J. 
Published: June 2010

ObjectiveThe goal of this study is to test the efficacy of the Memory Module of the REHACOP (Cognitive Training Program for Psychosis, Ojeda, Peña, 2006), in the improvement of cognition in patients with chronic schizophrenia (CS). Chronic patients present a moderate to severe cognitive performance on verbal memory and the severity of the illness and variables associated to the course of the diagnosis prevent them from improving cognition with traditional treatments.Methods57 patients with CS (illness duration, 10.17±7.22) were allocated randomly into either REHACOP (N=27) or control group (N=30). The REHACOP group received memory training with structured sessions 3 times per week for 8 weeks. Control group attended occupational therapy with the same frequency and timetables. Verbal Learning and Memory (Hopkins Verbal Learning Test; HVLT) and Working Memory (Digits Backwards from WAIS-III) were assessed at baseline and after the intervention.ResultsRepeated measures of MANOVA showed that the interaction term groupXtime was significant for all the memory measures, suggesting REHACOP group improved significantly when compared to controls. Specifically, the interaction term F value was significant for HVLT learning (F=6.78, p < 0.01), HVLT Long-term memory (F=7.02, p < 0.01) and working memory (Digits Backward (F=10.04, p < 0.01), and Sum (F=11.39, p < 0.01).ConclusionsPatients with CS improved significantly in all memory impairments when compared to those receiving other treatment. This study supports the efficacy of the REHACOP in the intervention of memory impairments in patients with schizophrenia, in spite of the severity.
P03-123 - Validation of the Spanish Version of the Subjective Well-Being Under Neuroleptic Scale (SWN) in Patients with Schizophrenia
Authors: Sanjuan J. , Haro J.M. , Maurino J. , Diez T. , Ballesteros J. 
Published: June 2010

ObjectiveTo assess the psychometric properties of the Spanish version of the SWN scale, an instrument which evaluates the subjective experience of psychotic patients towards neuroleptic treatment.MethodsA validation study (feasibility, reliability, and validity) was conducted in 20 psychiatric centers. Patients were evaluated with the PANSS, the CGI severity scale and the SWN-20. A re-test was conducted one week after baseline. The study included clinically stabilized outpatients diagnosed with schizophrenia (DSM-IV-TR criteria) who were on treatment as usual. The SWN used in this study consists of 20 questions answered on a 6-point Likert scale. The total score ranges from 20 to 120 points (higher scores indicating better well-being). The original version was back-translated and a focus group was conducted to improve the comprehension of the items.Results97 patients were included. Seventy-two percent of them (70) were male. Mean age was 35 years (SD = 10.0). Mean SWN total score: 83.5 (SD = 14.0). Internal homogeneity: 0.86. Test-retest in clinically stable patients was 0.89. SWN correlated significantly with the PANSS, but not with the DAI-10. Patients with none-mild clinical affectation had higher SWN scores, indicating a better subjective well-being, and vice versa.ConclusionsThe subjective experience of psychotic patients towards treatment is a key factor in therapeutic adherence, quality of life, and clinical outcome. The Spanish version of the SWN scale showed good psychometric properties in a sample of schizophrenic stabilized outpatients. SWN scale constitutes a valuable addition to evaluate patients’ subjective well-being.
P03-126 - Patient Functioning with Flexible Doses of Paliperidone ER - a 6-month Prospective Study
Authors: Schreiner A. , Hoeben D. , Lahaye M. , Tessier C. , Ivanov M. , Millet B. , Rembeck B. , Turczynski J. , Smeraldi E. 
Published: June 2010

ObjectiveTo explore changes in functioning with flexible doses of paliperidone ER in a large international study in patients with schizophrenia previously unsuccessfully treated with other oral antipsychotics.MethodsProspective 6-month open-label study. Functioning was assessed using the Personal and Social Performance Scale (PSP), including four domains:(1)personal and social relationships,(2)socially useful activities including work and study,(3)self care and(4)disturbing and aggressive behavior.Results1812 patients were included (59.9% male, mean age 40.1±12.6 years, 75.8% paranoid schizophrenia); most were enrolled because of lack of efficacy (n=1026) or lack of tolerability (n=490) with prior antipsychotic treatment. The median mode dose of paliperidone ER was 6 mg/day. 70.7% of patients completed the study. Most frequent reasons for early discontinuation were patient choice (8.8%), lack of efficacy or adverse event (5.1% each). AEs reported in >= 5% of patients were insomnia (9.2%) and anxiety (7.2%). Mean total baseline PSP score was 57.7±14.5, which improved to 64.1±15.6 at endpoint (mean change +6.4±13.5; 95% confidence interval 5.8;7.0, p< 0.0001); 49.0% of patients improved by at least one 10-point category in PSP. At baseline, 84.3% of patients had moderate to severe functional impairment, mostly driven by at least marked difficulties in socially useful activities (46.4.%) and personal and social relationships (36.4%). These percentages decreased to 30.6% and 22.9%, respectively.ConclusionIn this large prospective flexible-dose study, results from recent randomized controlled studies are supported that paliperidone ER is associated with a clinically meaningful improvement of functioning in patients with schizophrenia.
P03-131 - Nithsdale Schizophrenia Survey: Use of Antipsychotic Medications in a Schizophrenia Population
Authors: Shivashankar S. , Telfer S. , Arunagiriraj J. , McKinnon M. , McCreadie R. 
Published: June 2010

AimsAntipsychotics are mainstay treatment in schizophrenia; atypicals including clozapine were widely used. Clozapine was considered different due to its distinct effectiveness. We report the clinical profile of these groups.MethodIn Nithsdale, South-west Scotland, the schizophrenia population was identified by ‘key informant’ method in 2006. The clinical variables were determined and compared between the groups.ResultsThe study identified 205 people with schizophrenia (point prevalence: 3.7/1000 general population) of which 131(64%) took part in the study. 22(17%) were receiving typicals, 63(48%) atypicals excluding clozapine, 29(22%) clozapine, 8(6%) combination of typical and atypicals, and 9(7%) were on no antipsychotic medications.Comparison between atypicals excluding clozapine, typicals and clozapine groups showed: clozapine group were younger than atypicals and typicals (Mean years: 43,54 and 62, p=< 0.001). The length of illness was longer in typicals than atypicals and clozapine (Mean years: 35,24 and 18,p=0.002).With mental state, clozapine group had higher score in positive subscore of PANSS than that of atypicals and typicals (Mean: 1.83,1.52 and 1.21, p=< 0.001); while there were no significant differences in the negative subscore (Mean: 2.11,2.01 and 1.77, p=0.24).Tardive dyskinesia was more prevalent in typicals and clozapine groups than atypicals as assessed by AIMS scale (Mean: 41,41 and 18, p=0.02); while there were no significant differences between the three groups in the severity of parkinsonism as assessed by Simpson & Angus scale (Mean: 0.34,0.36 and 0.25, p=0.37).ConclusionsAtypicals including clozapine were no better than typicals in symptom control or in the neurological side effect profile.
P03-134 - Does the Frequency of Tobacco Smoking in Patients with Schizophrenia Varies with Regard to the Type of Antipsychotic Drugs?
Authors: Softic R. , Sutovic A. 
Published: June 2010

BackgroundTobacco smoking is considered as one of leading preventable causes of death. High prevalence of tobacco smoking was reported among individuals with mental illnesses, and it is extremely high among patients with Schizophrenia. It is possible that antipsychotic drugs side effects are contributing to this negative trend. Objective of this paper was to establish frequency of cigarette smoking among patients with Schizophrenia hospitalized at the psychiatry clinic and to determinate the difference in frequencies of cigarette smoking among patients with Schizophrenia treated with first or second generation antipsychotics.MethodsStudy included 60 patients with Schizophrenia treated with antipsychotics for period of six months or longer. Experimental group included 30 patients treated with second generation antipsychotics, and control group included 30 patients treated with first generation antipsychotics. Descriptive statistical methods are used. The levels of statistical significance between parametric data were determined by t- test, and between nonparametric data by chi square test. Level of significance was established at P < .05.ResultsIn this sample was 75% smokers, and out of this 46.6% consume up to 20 cigarettes per day, 40% consume 20 to 40 cigarettes, 8.8% between 40-60 cigarettes, and 4.4% consume over 60 cigarettes per day. There was no significant differences between groups of patients treated with first and second generation antipsychotics.ConclusionTobacco smoking is very frequent among patients with Schizophrenia. In this study we did not found significant difference in frequency of tobacco smoking between groups of patients treated with first or second generation antipsychotics.